niacin has been researched along with Weight Loss in 29 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective was to evaluate the effects of niacin on intestinal immunity, microbial community and intestinal barrier in weaned piglets during starvation." | 9.41 | Effects of niacin on intestinal immunity, microbial community and intestinal barrier in weaned piglets during starvation. ( Chen, Y; Feng, J; Jiang, Z; Wang, L; Wu, Q; Xiong, Y; Yi, H, 2021) |
| "The efficacy of optimal doses of highly bioavailable (-)-hydroxycitric acid (HCA-SX) alone and in combination with niacin-bound chromium (NBC) and a standardized Gymnema sylvestre extract (GSE) on weight loss in moderately obese subjects was evaluated by monitoring changes in body weight, body mass index (BMI), appetite, lipid profiles, serum leptin and excretion of urinary fat metabolites." | 9.11 | Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. ( Bagchi, D; Bagchi, M; Dey, DK; Preuss, HG; Rao, CV; Satyanarayana, S, 2004) |
| "The objective was to evaluate the effects of niacin on intestinal immunity, microbial community and intestinal barrier in weaned piglets during starvation." | 5.41 | Effects of niacin on intestinal immunity, microbial community and intestinal barrier in weaned piglets during starvation. ( Chen, Y; Feng, J; Jiang, Z; Wang, L; Wu, Q; Xiong, Y; Yi, H, 2021) |
| "The efficacy of optimal doses of highly bioavailable (-)-hydroxycitric acid (HCA-SX) alone and in combination with niacin-bound chromium (NBC) and a standardized Gymnema sylvestre extract (GSE) on weight loss in moderately obese subjects was evaluated by monitoring changes in body weight, body mass index (BMI), appetite, lipid profiles, serum leptin and excretion of urinary fat metabolites." | 5.11 | Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. ( Bagchi, D; Bagchi, M; Dey, DK; Preuss, HG; Rao, CV; Satyanarayana, S, 2004) |
| "This pilot study was designed to determine whether 600 microg niacin-bound chromium ingested daily over 2 months by African-American women undergoing a modest dietary and exercise regimen influences weight loss and body composition." | 5.09 | Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. ( Crawford, V; Preuss, HG; Scheckenbach, R, 1999) |
| "Pellagra is a nutritional disease caused by the deficiency of niacin." | 3.79 | Pellagra revealing a congenital duodenal diaphragm in an adult. ( Ahmed, S; Farah, J; Haykel, B; Houcine, M; Khouloud, B; Yacine, BS; Zoubeir, BS, 2013) |
| "Pellagra is a nutritional disease caused by the deficiency of niacin." | 3.78 | Letter: Pellagra as the initial presentation of Crohn disease. ( Fernandes, IC; Oliveira, A; Pinto-Almeida, T; Rosmaninho, A; Sanches, M; Selores, M; Vilaça, S, 2012) |
| " This was managed non-operatively with lumbar cerebrospinal fluid tap, weight reduction, nicotinic acid and acetazolamide." | 3.73 | Non-operative management of benign intracranial hypertension presenting with complete visual loss and deafness. ( Idowu, OE; Malomo, AO; Nwaorgu, OG; Oluleye, TS; Shokunbi, MT, 2006) |
| "Furthermore, severe hypertriglyceridemia is associated with an increased risk of acute pancreatitis, irrespective of its effect on risk of cardiovascular disease." | 2.44 | Hypertriglyceridemia: its etiology, effects and treatment. ( Al-Shali, KZ; Hegele, RA; Yuan, G, 2007) |
| "Hypertriglyceridemia is a well-known risk factor for pancreatitis." | 2.38 | The triglyceride connection in atherosclerosis. ( Geurian, K; Pinson, JB; Weart, CW, 1992) |
| "Dyslipidemia is frequently found in association with obesity." | 1.37 | Obesity and dyslipidemia. ( Repas, T, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (20.69) | 18.2507 |
| 2000's | 15 (51.72) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, J | 1 |
| Wang, L | 1 |
| Chen, Y | 1 |
| Xiong, Y | 1 |
| Wu, Q | 1 |
| Jiang, Z | 1 |
| Yi, H | 1 |
| Palzer, L | 1 |
| Bader, JJ | 1 |
| Angel, F | 1 |
| Witzel, M | 1 |
| Blaser, S | 1 |
| McNeil, A | 1 |
| Wandersee, MK | 1 |
| Leu, NA | 1 |
| Lengner, CJ | 1 |
| Cho, CE | 1 |
| Welch, KD | 1 |
| Kirkland, JB | 1 |
| Meyer, RG | 1 |
| Meyer-Ficca, ML | 1 |
| Misra, A | 1 |
| Bhardwaj, S | 1 |
| Cardenas, GA | 1 |
| Lavie, CJ | 1 |
| Cardenas, V | 1 |
| Milani, RV | 1 |
| McCullough, PA | 1 |
| Merkel, M | 1 |
| Sanyal, S | 1 |
| Kuvin, JT | 1 |
| Karas, RH | 1 |
| Custodis, F | 1 |
| Laufs, U | 1 |
| Repas, T | 1 |
| Rosmaninho, A | 1 |
| Sanches, M | 1 |
| Fernandes, IC | 1 |
| Pinto-Almeida, T | 1 |
| Vilaça, S | 1 |
| Oliveira, A | 1 |
| Selores, M | 1 |
| Preuss, HG | 2 |
| Bagchi, D | 1 |
| Bagchi, M | 1 |
| Rao, CV | 1 |
| Dey, DK | 1 |
| Satyanarayana, S | 1 |
| Benz, R | 1 |
| Suter, PM | 1 |
| Ashen, MD | 1 |
| Blumenthal, RS | 1 |
| Espinosa-Larrañaga, F | 1 |
| Vejar-Jalaf, M | 1 |
| Medina-Santillán, R | 1 |
| Malomo, AO | 1 |
| Idowu, OE | 1 |
| Shokunbi, MT | 1 |
| Nwaorgu, OG | 1 |
| Oluleye, TS | 1 |
| Pins, JJ | 1 |
| Keenan, JM | 1 |
| Joseph, A | 1 |
| Kothari, T | 1 |
| Venkatesh, S | 1 |
| Yuan, G | 1 |
| Al-Shali, KZ | 1 |
| Hegele, RA | 1 |
| Brunzell, JD | 1 |
| Yavasoglu, I | 1 |
| Kadikoylu, G | 1 |
| Bolaman, Z | 1 |
| Röggla, G | 1 |
| Fasan, M | 1 |
| Kapiotis, S | 1 |
| Holub, BJ | 1 |
| Kigutha, HN | 1 |
| van Staveren, WA | 1 |
| Wijnhoven, TM | 1 |
| Hautvast, JG | 1 |
| Rauma, AL | 1 |
| Nenonen, M | 1 |
| Helve, T | 1 |
| Hänninen, O | 1 |
| Avery, BR | 1 |
| Grundy, SM | 1 |
| Crawford, V | 1 |
| Scheckenbach, R | 1 |
| Geurian, K | 1 |
| Pinson, JB | 1 |
| Weart, CW | 1 |
| Khouloud, B | 1 |
| Haykel, B | 1 |
| Ahmed, S | 1 |
| Houcine, M | 1 |
| Yacine, BS | 1 |
| Farah, J | 1 |
| Zoubeir, BS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment Study for Severe High-Density Lipoprotein Deficiency[NCT00458055] | 19 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| Effect of Tomato Consumption on Serum High Density Lipoprotein-cholesterol Levels. A Randomized, Open-label, Single Blind, Clinical Trial[NCT01342666] | 50 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To evaluate the effect of two daily tomatoes consumption on HDL-c levels. (NCT01342666)
Timeframe: Baseline and after one month
| Intervention | mg/dL (Mean) | |
|---|---|---|
| Baseline HDL-c | Final HDL-c | |
| Cucumber Consumption | 36.8 | 35.8 |
| Tomato Consumption | 36.5 | 41.6 |
12 reviews available for niacin and Weight Loss
| Article | Year |
|---|---|
The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Topics: Apolipoprotein A-I; Atherosclerosis; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; C | 2008 |
[Diabetic dyslipoproteinemia: beyond LDL].
Topics: Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Chy | 2009 |
Niacin and laropiprant.
Topics: Cholesterol, HDL; Drug Tolerance; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; | 2010 |
[Hypertricglyceridemia: prognostic impact and treatment options].
Topics: Adult; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diet, R | 2011 |
[Low HDL-cholesterol, high triglycerides--well known but often ignored].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol, HDL; Clofibric A | 2004 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Dietary and nutraceutical options for managing the hypertriglyceridemic patient.
Topics: Dietary Carbohydrates; Energy Intake; Evidence-Based Medicine; Exercise; Fasting; Fish Oils; Humans; | 2006 |
Hypertriglyceridemia: its etiology, effects and treatment.
Topics: Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase | 2007 |
Clinical practice. Hypertriglyceridemia.
Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Clofibric Acid; Combined Modality Therapy; Diet Therapy | 2007 |
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
Topics: Cholesterol, HDL; Cholesterol, VLDL; Clinical Trials as Topic; Consensus Development Conferences as | 1998 |
Raising HDL cholesterol: a worthwhile goal?
Topics: Cholesterol, HDL; Drug Combinations; Estrogen Replacement Therapy; Exercise; Guidelines as Topic; He | 2002 |
The triglyceride connection in atherosclerosis.
Topics: Alcohol Drinking; Arteriosclerosis; Coronary Disease; Diabetes Complications; Diet; Exercise; Humans | 1992 |
4 trials available for niacin and Weight Loss
| Article | Year |
|---|---|
Effects of niacin on intestinal immunity, microbial community and intestinal barrier in weaned piglets during starvation.
Topics: Animals; Cells, Cultured; Colon; Diarrhea; Female; Gastrointestinal Microbiome; Histone Deacetylases | 2021 |
Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss.
Topics: Adult; Appetite; Biomarkers; Body Mass Index; Chromium; Citrates; Double-Blind Method; Drug Therapy, | 2004 |
Effect of a strict vegan diet on energy and nutrient intakes by Finnish rheumatoid patients.
Topics: Arthritis, Rheumatoid; Cooking; Diet Surveys; Diet, Vegetarian; Energy Intake; Energy Metabolism; Fe | 1993 |
Effects of niacin-bound chromium supplementation on body composition in overweight African-American women.
Topics: Adipose Tissue; Black People; Blood Chemical Analysis; Body Composition; Body Weight; Chromium; Cros | 1999 |
13 other studies available for niacin and Weight Loss
| Article | Year |
|---|---|
Alpha-Amino-Beta-Carboxy-Muconate-Semialdehyde Decarboxylase Controls Dietary Niacin Requirements for NAD
Topics: Acetyl Coenzyme A; Animals; Carboxy-Lyases; Diet; Doxycycline; Humans; Lactates; Liver; Mice, Inbred | 2018 |
Management of the Metabolic Syndrome and the Obese Patient with Metabolic Disturbances: South Asian Perspective.
Topics: Adipose Tissue; Asia; Asian People; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Dietar | 2015 |
Obesity and dyslipidemia.
Topics: Anti-Obesity Agents; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dyslipidemias; Humans; H | 2011 |
Letter: Pellagra as the initial presentation of Crohn disease.
Topics: Abdominal Pain; Albumins; Anti-Infective Agents; Anti-Inflammatory Agents; Crohn Disease; Diarrhea; | 2012 |
The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor.
Topics: Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Combined Modality Therapy; Diabetes Complicat | 2005 |
Non-operative management of benign intracranial hypertension presenting with complete visual loss and deafness.
Topics: Acetazolamide; Adolescent; Blindness; Deafness; Diuretics; Female; Humans; Niacin; Pseudotumor Cereb | 2006 |
Niacin toxicity: a rare presentation mimicking malignancy.
Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Bacterial Proteins; Bilirubin; Carcinoembryonic Anti | 2006 |
Treating hypertriglyceridemia.
Topics: Adult; Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Heparin; Humans; Hydroxymethylglutar | 2007 |
Treating hypertriglyceridemia.
Topics: Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase | 2007 |
Treating hypertriglyceridemia.
Topics: Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Fatty Acids, Omega-3; Humans; Hydroxymethyl | 2007 |
Maternal nutritional status may be stressed by seasonal fluctuations in food availability: evidence from rural women in Kenya.
Topics: Adult; Anthropometry; Ascorbic Acid; Body Weight; Calcium; Diet; Eating; Female; Food Analysis; Food | 1995 |
Treatment of the patient with primary familial heterozygous hypercholesterolemia.
Topics: Aged; Colestipol; Coronary Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Exercise; Femal | 1995 |
Pellagra revealing a congenital duodenal diaphragm in an adult.
Topics: Adult; Diaphragm; Duodenal Obstruction; Female; Humans; Hyperpigmentation; Malnutrition; Niacinamide | 2013 |